Clinical	B:C2985631
and	O
radiological	O
outcome	O
following	O
pneumothorax	O
after	O
endoscopic	O
lung	I:C0375931
volume	I:C0375931
reduction	I:C0375931
with	O
valves	O
Valve	O
implantation	O
has	O
evolved	O
as	O
a	O
therapy	O
for	O
patients	O
with	O
advanced	O
emphysema	O
.	O

Clinical	O
and	O
radiological	B:C0043299
outcome	O
following	O
pneumothorax	O
after	O
endoscopic	O
lung	I:C0375931
volume	I:C0375931
reduction	I:C0375931
with	O
valves	O
Valve	O
implantation	O
has	O
evolved	O
as	O
a	O
therapy	O
for	O
patients	O
with	O
advanced	O
emphysema	O
.	O

Clinical	O
and	O
radiological	O
outcome	O
following	O
pneumothorax	B:C0032326
after	O
endoscopic	O
lung	I:C0375931
volume	I:C0375931
reduction	I:C0375931
with	O
valves	O
Valve	O
implantation	O
has	O
evolved	O
as	O
a	O
therapy	O
for	O
patients	O
with	O
advanced	O
emphysema	O
.	O

Clinical	O
and	O
radiological	O
outcome	O
following	O
pneumothorax	O
after	O
endoscopic	B:C0375931
lung	I:C0375931
volume	I:C0375931
reduction	I:C0375931
with	O
valves	O
Valve	O
implantation	O
has	O
evolved	O
as	O
a	O
therapy	O
for	O
patients	O
with	O
advanced	O
emphysema	O
.	O

Clinical	O
and	O
radiological	O
outcome	O
following	O
pneumothorax	O
after	O
endoscopic	O
lung	I:C0375931
volume	I:C0375931
reduction	I:C0375931
with	O
valves	B:C0042296
Valve	O
implantation	O
has	O
evolved	O
as	O
a	O
therapy	O
for	O
patients	O
with	O
advanced	O
emphysema	O
.	O

Clinical	O
and	O
radiological	O
outcome	O
following	O
pneumothorax	O
after	O
endoscopic	O
lung	I:C0375931
volume	I:C0375931
reduction	I:C0375931
with	O
valves	O
Valve	B:C0042296
implantation	O
has	O
evolved	O
as	O
a	O
therapy	O
for	O
patients	O
with	O
advanced	O
emphysema	O
.	O

Clinical	O
and	O
radiological	O
outcome	O
following	O
pneumothorax	O
after	O
endoscopic	O
lung	I:C0375931
volume	I:C0375931
reduction	I:C0375931
with	O
valves	O
Valve	O
implantation	B:C0021107
has	O
evolved	O
as	O
a	O
therapy	O
for	O
patients	O
with	O
advanced	O
emphysema	O
.	O

Clinical	O
and	O
radiological	O
outcome	O
following	O
pneumothorax	O
after	O
endoscopic	O
lung	I:C0375931
volume	I:C0375931
reduction	I:C0375931
with	O
valves	O
Valve	O
implantation	O
has	O
evolved	O
as	O
a	O
therapy	B:C0087111
for	O
patients	O
with	O
advanced	O
emphysema	O
.	O

Clinical	O
and	O
radiological	O
outcome	O
following	O
pneumothorax	O
after	O
endoscopic	O
lung	I:C0375931
volume	I:C0375931
reduction	I:C0375931
with	O
valves	O
Valve	O
implantation	O
has	O
evolved	O
as	O
a	O
therapy	O
for	O
patients	O
with	O
advanced	O
emphysema	B:C0034067
.	O

Although	O
it	O
is	O
a	O
minimally	B:C0282624
invasive	I:C0282624
treatmen	I:C0282624
t	O
,	O
it	O
is	O
associated	O
with	O
complications	O
,	O
the	O
most	O
common	O
being	O
pneumothorax	O
.	O

Although	O
it	O
is	O
a	O
minimally	O
invasive	I:C0282624
treatmen	I:C0282624
t	O
,	O
it	O
is	O
associated	O
with	O
complications	B:C0009566
,	O
the	O
most	O
common	O
being	O
pneumothorax	O
.	O

Although	O
it	O
is	O
a	O
minimally	O
invasive	I:C0282624
treatmen	I:C0282624
t	O
,	O
it	O
is	O
associated	O
with	O
complications	O
,	O
the	O
most	O
common	O
being	O
pneumothorax	B:C0032326
.	O

Pneumothorax	B:C0032326
occurs	O
due	O
to	O
the	O
rapid	O
target	O
lobe	O
volume	O
reduction	I:C0524689
and	O
may	O
be	O
a	O
predictor	O
of	O
clinical	O
benefit	O
despite	O
this	O
complication	O
.	O

Pneumothorax	O
occurs	O
due	O
to	O
the	O
rapid	O
target	O
lobe	B:C0225752
volume	O
reduction	I:C0524689
and	O
may	O
be	O
a	O
predictor	O
of	O
clinical	O
benefit	O
despite	O
this	O
complication	O
.	O

Pneumothorax	O
occurs	O
due	O
to	O
the	O
rapid	O
target	O
lobe	O
volume	B:C0524689
reduction	I:C0524689
and	O
may	O
be	O
a	O
predictor	O
of	O
clinical	O
benefit	O
despite	O
this	O
complication	O
.	O

Pneumothorax	O
occurs	O
due	O
to	O
the	O
rapid	O
target	O
lobe	O
volume	O
reduction	I:C0524689
and	O
may	O
be	O
a	O
predictor	O
of	O
clinical	O
benefit	O
despite	O
this	O
complication	B:C0009566
.	O

The	O
objective	B:C0018017
of	O
this	O
study	O
was	O
to	O
conduct	O
an	O
exploratory	O
data	O
analysis	O
of	O
patients	O
who	O
developed	O
a	O
pneumothorax	O
following	O
endoscopic	O
valve	I:C0087111
therapy	I:C0087111
for	O
emphysema	O
.	O

The	O
objective	O
of	O
this	O
study	B:C2603343
was	O
to	O
conduct	O
an	O
exploratory	O
data	O
analysis	O
of	O
patients	O
who	O
developed	O
a	O
pneumothorax	O
following	O
endoscopic	O
valve	I:C0087111
therapy	I:C0087111
for	O
emphysema	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
conduct	O
an	O
exploratory	O
data	O
analysis	O
of	O
patients	O
who	O
developed	O
a	O
pneumothorax	B:C0032326
following	O
endoscopic	O
valve	I:C0087111
therapy	I:C0087111
for	O
emphysema	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
conduct	O
an	O
exploratory	O
data	O
analysis	O
of	O
patients	O
who	O
developed	O
a	O
pneumothorax	O
following	O
endoscopic	B:C0087111
valve	I:C0087111
therapy	I:C0087111
for	O
emphysema	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
conduct	O
an	O
exploratory	O
data	O
analysis	O
of	O
patients	O
who	O
developed	O
a	O
pneumothorax	O
following	O
endoscopic	O
valve	I:C0087111
therapy	I:C0087111
for	O
emphysema	B:C0034067
.	O

This	O
study	B:C2603343
performed	O
a	O
retrospective	O
evaluation	I:C0035363
of	O
pneumothorax	O
management	O
and	O
the	O
impact	O
of	O
pneumothorax	O
on	O
clinical	O
outcomes	I:C2985631
in	O
70	O
patients	O
following	O
valve	O
therapy	I:C0087111
in	O
381	O
consecutive	O
patients	O
.	O

This	O
study	O
performed	O
a	O
retrospective	B:C0035363
evaluation	I:C0035363
of	O
pneumothorax	O
management	O
and	O
the	O
impact	O
of	O
pneumothorax	O
on	O
clinical	O
outcomes	I:C2985631
in	O
70	O
patients	O
following	O
valve	O
therapy	I:C0087111
in	O
381	O
consecutive	O
patients	O
.	O

This	O
study	O
performed	O
a	O
retrospective	O
evaluation	I:C0035363
of	O
pneumothorax	B:C0032326
management	O
and	O
the	O
impact	O
of	O
pneumothorax	O
on	O
clinical	O
outcomes	I:C2985631
in	O
70	O
patients	O
following	O
valve	O
therapy	I:C0087111
in	O
381	O
consecutive	O
patients	O
.	O

This	O
study	O
performed	O
a	O
retrospective	O
evaluation	I:C0035363
of	O
pneumothorax	O
management	B:C0376636
and	O
the	O
impact	O
of	O
pneumothorax	O
on	O
clinical	O
outcomes	I:C2985631
in	O
70	O
patients	O
following	O
valve	O
therapy	I:C0087111
in	O
381	O
consecutive	O
patients	O
.	O

This	O
study	O
performed	O
a	O
retrospective	O
evaluation	I:C0035363
of	O
pneumothorax	O
management	O
and	O
the	O
impact	O
of	O
pneumothorax	B:C0032326
on	O
clinical	O
outcomes	I:C2985631
in	O
70	O
patients	O
following	O
valve	O
therapy	I:C0087111
in	O
381	O
consecutive	O
patients	O
.	O

This	O
study	O
performed	O
a	O
retrospective	O
evaluation	I:C0035363
of	O
pneumothorax	O
management	O
and	O
the	O
impact	O
of	O
pneumothorax	O
on	O
clinical	B:C2985631
outcomes	I:C2985631
in	O
70	O
patients	O
following	O
valve	O
therapy	I:C0087111
in	O
381	O
consecutive	O
patients	O
.	O

This	O
study	O
performed	O
a	O
retrospective	O
evaluation	I:C0035363
of	O
pneumothorax	O
management	O
and	O
the	O
impact	O
of	O
pneumothorax	O
on	O
clinical	O
outcomes	I:C2985631
in	O
70	O
patients	O
following	O
valve	B:C0087111
therapy	I:C0087111
in	O
381	O
consecutive	O
patients	O
.	O

Pneumothorax	B:C0032326
rate	O
following	O
valve	O
therapy	I:C0087111
was	O
18	O
%	O
.	O

Pneumothorax	O
rate	O
following	O
valve	B:C0087111
therapy	I:C0087111
was	O
18	O
%	O
.	O

Pneumothorax	B:C0032326
management	O
consisted	O
of	O
chest	O
tube	I:C0189476
insertion	I:C0189476
,	O
valve	O
removal	O
,	O
and	O
surgical	O
intervention	I:C0549433
in	O
87	O
%	O
(	O
61/70	O
)	O
,	O
44	O
%	O
(	O
31/70	O
)	O
,	O
and	O
19	O
%	O
(	O
13/70	O
)	O
of	O
the	O
patients	O
,	O
respectively	O
.	O

Pneumothorax	O
management	B:C0376636
consisted	O
of	O
chest	O
tube	I:C0189476
insertion	I:C0189476
,	O
valve	O
removal	O
,	O
and	O
surgical	O
intervention	I:C0549433
in	O
87	O
%	O
(	O
61/70	O
)	O
,	O
44	O
%	O
(	O
31/70	O
)	O
,	O
and	O
19	O
%	O
(	O
13/70	O
)	O
of	O
the	O
patients	O
,	O
respectively	O
.	O

Pneumothorax	O
management	O
consisted	O
of	O
chest	B:C0189476
tube	I:C0189476
insertion	I:C0189476
,	O
valve	O
removal	O
,	O
and	O
surgical	O
intervention	I:C0549433
in	O
87	O
%	O
(	O
61/70	O
)	O
,	O
44	O
%	O
(	O
31/70	O
)	O
,	O
and	O
19	O
%	O
(	O
13/70	O
)	O
of	O
the	O
patients	O
,	O
respectively	O
.	O

Pneumothorax	O
management	O
consisted	O
of	O
chest	O
tube	I:C0189476
insertion	I:C0189476
,	O
valve	B:C0042296
removal	O
,	O
and	O
surgical	O
intervention	I:C0549433
in	O
87	O
%	O
(	O
61/70	O
)	O
,	O
44	O
%	O
(	O
31/70	O
)	O
,	O
and	O
19	O
%	O
(	O
13/70	O
)	O
of	O
the	O
patients	O
,	O
respectively	O
.	O

Pneumothorax	O
management	O
consisted	O
of	O
chest	O
tube	I:C0189476
insertion	I:C0189476
,	O
valve	O
removal	B:C0015252
,	O
and	O
surgical	O
intervention	I:C0549433
in	O
87	O
%	O
(	O
61/70	O
)	O
,	O
44	O
%	O
(	O
31/70	O
)	O
,	O
and	O
19	O
%	O
(	O
13/70	O
)	O
of	O
the	O
patients	O
,	O
respectively	O
.	O

Pneumothorax	O
management	O
consisted	O
of	O
chest	O
tube	I:C0189476
insertion	I:C0189476
,	O
valve	O
removal	O
,	O
and	O
surgical	B:C0549433
intervention	I:C0549433
in	O
87	O
%	O
(	O
61/70	O
)	O
,	O
44	O
%	O
(	O
31/70	O
)	O
,	O
and	O
19	O
%	O
(	O
13/70	O
)	O
of	O
the	O
patients	O
,	O
respectively	O
.	O

Despite	O
pneumothorax	B:C0032326
,	O
patients	O
experienced	O
modest	O
but	O
significant	O
improvements	O
in	O
lung	O
function	I:C0231921
parameters	O
(	O
forced	O
expiratory	I:C0016529
volume	I:C0016529
in	O
1	O
second	O
:	O
55±148	O
mL	O
,	O
residual	O
volume	I:C0035190
:	O
-	O
390±964	O
mL	O
,	O
total	O
lung	I:C0040509
capacity	I:C0040509
:	O
-	O
348±876	O
;	O
all	O
P	O
<	O
0.05	O
)	O
.	O

Despite	O
pneumothorax	O
,	O
patients	O
experienced	O
modest	O
but	O
significant	O
improvements	O
in	O
lung	B:C0231921
function	I:C0231921
parameters	O
(	O
forced	O
expiratory	I:C0016529
volume	I:C0016529
in	O
1	O
second	O
:	O
55±148	O
mL	O
,	O
residual	O
volume	I:C0035190
:	O
-	O
390±964	O
mL	O
,	O
total	O
lung	I:C0040509
capacity	I:C0040509
:	O
-	O
348±876	O
;	O
all	O
P	O
<	O
0.05	O
)	O
.	O

Despite	O
pneumothorax	O
,	O
patients	O
experienced	O
modest	O
but	O
significant	O
improvements	O
in	O
lung	O
function	I:C0231921
parameters	O
(	O
forced	B:C0016529
expiratory	I:C0016529
volume	I:C0016529
in	O
1	O
second	O
:	O
55±148	O
mL	O
,	O
residual	O
volume	I:C0035190
:	O
-	O
390±964	O
mL	O
,	O
total	O
lung	I:C0040509
capacity	I:C0040509
:	O
-	O
348±876	O
;	O
all	O
P	O
<	O
0.05	O
)	O
.	O

Despite	O
pneumothorax	O
,	O
patients	O
experienced	O
modest	O
but	O
significant	O
improvements	O
in	O
lung	O
function	I:C0231921
parameters	O
(	O
forced	O
expiratory	I:C0016529
volume	I:C0016529
in	O
1	O
second	O
:	O
55±148	O
mL	O
,	O
residual	B:C0035190
volume	I:C0035190
:	O
-	O
390±964	O
mL	O
,	O
total	O
lung	I:C0040509
capacity	I:C0040509
:	O
-	O
348±876	O
;	O
all	O
P	O
<	O
0.05	O
)	O
.	O

Despite	O
pneumothorax	O
,	O
patients	O
experienced	O
modest	O
but	O
significant	O
improvements	O
in	O
lung	O
function	I:C0231921
parameters	O
(	O
forced	O
expiratory	I:C0016529
volume	I:C0016529
in	O
1	O
second	O
:	O
55±148	O
mL	O
,	O
residual	O
volume	I:C0035190
:	O
-	O
390±964	O
mL	O
,	O
total	B:C0040509
lung	I:C0040509
capacity	I:C0040509
:	O
-	O
348±876	O
;	O
all	O
P	O
<	O
0.05	O
)	O
.	O

Persistent	O
lobar	B:C0004144
atelectasis	I:C0004144
3	O
months	O
after	O
recovering	O
from	O
pneumothorax	O
,	O
which	O
was	O
associated	O
with	O
relevant	O
clinical	O
improvement	O
,	O
was	O
observed	O
in	O
only	O
21	O
%	O
(	O
15/70	O
)	O
of	O
the	O
patients	O
.	O

Persistent	O
lobar	O
atelectasis	I:C0004144
3	O
months	O
after	O
recovering	O
from	O
pneumothorax	B:C0032326
,	O
which	O
was	O
associated	O
with	O
relevant	O
clinical	O
improvement	O
,	O
was	O
observed	O
in	O
only	O
21	O
%	O
(	O
15/70	O
)	O
of	O
the	O
patients	O
.	O

Pneumothorax	B:C0032326
is	O
a	O
frequent	O
severe	O
complication	O
following	O
valve	O
therapy	I:C0087111
that	O
requires	O
further	O
intervention	O
.	O

Pneumothorax	O
is	O
a	O
frequent	O
severe	O
complication	B:C0009566
following	O
valve	O
therapy	I:C0087111
that	O
requires	O
further	O
intervention	O
.	O

Pneumothorax	O
is	O
a	O
frequent	O
severe	O
complication	O
following	O
valve	B:C0087111
therapy	I:C0087111
that	O
requires	O
further	O
intervention	O
.	O

Pneumothorax	O
is	O
a	O
frequent	O
severe	O
complication	O
following	O
valve	O
therapy	I:C0087111
that	O
requires	O
further	O
intervention	B:C0184661
.	O

Nevertheless	O
,	O
the	O
pneumothorax	B:C0032326
does	O
not	O
impair	O
the	O
clinical	O
status	O
in	O
the	O
majority	O
of	O
patients	O
.	O

Patients	O
with	O
lobar	B:C0004144
atelectasis	I:C0004144
benefit	O
after	O
recovering	O
from	O
pneumothorax	O
in	O
terms	O
of	O
lung	O
function	I:C0231921
parameters	O
.	O

Patients	O
with	O
lobar	O
atelectasis	I:C0004144
benefit	O
after	O
recovering	O
from	O
pneumothorax	B:C0032326
in	O
terms	O
of	O
lung	O
function	I:C0231921
parameters	O
.	O

Patients	O
with	O
lobar	O
atelectasis	I:C0004144
benefit	O
after	O
recovering	O
from	O
pneumothorax	O
in	O
terms	O
of	O
lung	B:C0231921
function	I:C0231921
parameters	O
.	O

